Efficacy of Memantine Added to Cholinesterase Inhibitors on SIB Higher-Order Cognitive Domains: Pooled Post Hoc Analysis of 2 Randomized Controlled Trials in Patients With Moderate to Severe AD

被引：0
|
作者：
Schmitt, Frederick A. [1 ]
Grossberg, George T. [2 ]
Tariot, Pierre N. [3 ]
Hendrix, Suzanne [4 ]
Ellison, Noel [4 ]
Kerolous, Majid [5 ]
机构：
[1] Univ Kentucky, Lexington, KY USA
[2] St Louis Univ, St Louis, MO 63103 USA
[3] Univ Arizona, Banner Alzheimers Inst, Phoenix, AZ USA
[4] Pentara Corp, Salt Lake City, UT USA
[5] Allergan Plc, Madison, NJ USA
来源：
NEUROLOGY | 2019年 / 92卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P4.1-007
引用
收藏
页数：3
相关论文
共 42 条
  • [1] SIB Maintenance of Response With Memantine Added to Cholinesterase Inhibitors: Pooled Post Hoc Analysis of 2 Randomized Controlled Trials in Patients With Moderate to Severe AD
    Schmitt, Frederick A.
    Tariot, Pierre N.
    Grossberg, George T.
    Hendrix, Suzanne
    Ellison, Noel
    Kerolous, Majid
    NEUROLOGY, 2019, 92 (15)
  • [2] The Effects of Memantine Added to Cholinesterase Inhibitors on NPI Behavioral Domains: Pooled Post Hoc Analysis of 3 Randomized Controlled Trials in Patients With Moderate to Severe AD
    Cummings, Jeffrey L.
    Grossberg, George T.
    Porsteinsson, Anton P.
    Hendrix, Suzanne
    Ellison, Noel
    Kerolous, Majid
    NEUROLOGY, 2019, 92 (15)
  • [3] Efficacy of Memantine by Baseline Disease Severity: Post-hoc Analysis of Pooled Trials in Patients with Mild to Moderate Alzheimer's Disease
    Tocco, M.
    Hendrix, S.
    Miller, M. L.
    Pejovic, V.
    Graham, S. M.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2011, 59 : S124 - S124
  • [4] Daily Functioning Benefits of Adding Memantine to Stable Cholinesterase Treatment in Patients with Moderate to Severe Alzheimer's Disease: A Post Hoc Pooled Factor Analysis
    Alva, Gustavo
    Ellison, Noel
    Dass, Biplob
    Hendrix, Suzanne
    NEUROLOGY, 2016, 86
  • [5] Memantine ER Maintains Patient Response in Moderate to Severe Alzheimer's Disease: Post Hoc Analyses From a Randomized, Controlled, Clinical Trial of Patients Treated With Cholinesterase Inhibitors
    Grossberg, George T.
    Alva, Gustavo
    Hendrix, Suzanne
    Ellison, Noel
    Kane, Mary C.
    Edwards, John
    ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2018, 32 (03): : 173 - 178
  • [6] Efficacy of Lifitegrast Ophthalmic Solution, 5.0%, in Patients With Moderate to Severe Dry Eye Disease A Post Hoc Analysis of 2 Randomized Clinical Trials
    Holland, Edward J.
    Jackson, Mitchell A.
    Donnenfeld, Eric
    Piccolo, Rebecca
    Cohen, Alisa
    Barabino, Stefano
    Rolando, Maurizio
    Figueiredo, Francisco C.
    JAMA OPHTHALMOLOGY, 2021, 139 (11) : 1200 - 1208
  • [7] Efficacy and safety of memantine in patients with moderate-to-severe Alzheimer's disease: results of a pooled analysis of two randomized, double-blind, placebo-controlled trials in Japan
    Nakamura, Yu
    Kitamura, Shin
    Homma, Akira
    Shiosakai, Kazuhito
    Matsui, Daiju
    EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (07) : 913 - 925
  • [8] Effect of ertugliflozin on blood pressure in patients with type 2 diabetes mellitus: a post hoc pooled analysis of randomized controlled trials
    Liu, Jie
    Pong, Annpey
    Gallo, Silvina
    Darekar, Amanda
    Terra, Steven G.
    CARDIOVASCULAR DIABETOLOGY, 2019, 18 (1)
  • [9] Effect of ertugliflozin on blood pressure in patients with type 2 diabetes mellitus: a post hoc pooled analysis of randomized controlled trials
    Jie Liu
    Annpey Pong
    Silvina Gallo
    Amanda Darekar
    Steven G. Terra
    Cardiovascular Diabetology, 18
  • [10] Efficacy of anifrolumab across organ domains in patients with moderate-to-severe systemic lupus erythematosus: a post-hoc analysis of pooled data from the TULIP-1 and TULIP-2 trials
    Morand, Eric F.
    Furie, Richard A.
    Bruce, Ian N.
    Vital, Edward M.
    Dall'Era, Maria
    Maho, Emmanuelle
    Pineda, Lilia
    Tummala, Raj
    LANCET RHEUMATOLOGY, 2022, 4 (04): : E282 - E292
12345